Biocon To Launch Approved Generic Liraglutide ‘Expeditiously’ In India

The Firm Believes GLP-1s To Be The Key Drivers Of Its Future Growth

Marking its first vertically integrated GLP-1 product in India, Biocon said the generic liraglutide was approved under CDSCO’s Rule 101, which recognizes approvals from “established and referenced serious regulatory authorities.”

India's flag pinned on the map
(Shutterstock)

More from Generics

More from Generics Bulletin